Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial
Open Access
- 15 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 52 (3), 409-410
- https://doi.org/10.1093/rheumatology/kes274
Abstract
Are the conclusions supported by the data?Keywords
This publication has 7 references indexed in Scilit:
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trialArthritis & Rheumatism, 2012
- Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritisArthritis & Rheumatism, 2012
- Reporting of long-term extension studies: lack of consistency calls for consensusAnnals Of The Rheumatic Diseases, 2011
- Treating rheumatoid arthritis to target: recommendations of an international task forceAnnals Of The Rheumatic Diseases, 2010
- Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsAnnals Of The Rheumatic Diseases, 2008
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialArthritis & Rheumatism, 2005
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998